Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1949 2
1950 1
1951 1
1952 1
1956 2
1965 1
1968 9
1969 3
1971 3
1972 2
1973 9
1974 7
1975 11
1976 14
1977 11
1978 16
1979 5
1980 9
1981 22
1982 17
1983 16
1984 26
1985 15
1986 23
1987 22
1988 14
1989 13
1990 17
1991 22
1992 17
1993 21
1994 24
1995 21
1996 14
1997 14
1998 22
1999 26
2000 25
2001 27
2002 30
2003 38
2004 63
2005 54
2006 63
2007 78
2008 107
2009 126
2010 141
2011 167
2012 182
2013 210
2014 202
2015 254
2016 254
2017 265
2018 289
2019 313
2020 341
2021 428
2022 396
2023 355
2024 378
2025 343
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,950 results

Results by year

Filters applied: . Clear all
Page 1
Brazilian Guideline on Menopausal Cardiovascular Health - 2024.
Oliveira GMM, Almeida MCC, Arcelus CMA, Neto Espíndola L, Rivera MAM, Silva-Filho ALD, Marques-Santos C, Fernandes CE, Albuquerque CJDM, Freire CMV, Izar MCO, Costa MENC, Castro ML, Lemke VMG, Lucena AJG, Brandão AA, Macedo AVS, Polanczyk CA, Lantieri CJB, Nahas EP, Alexandre ERG, Campana EMG, Bragança ÉOV, Colombo FMC, Barbosa ICQ, Rivera IR, Kulak J, Moura LAZ, Pompei LM, Baccaro LFC, Barbosa MM, Rodrigues MAH, Albernaz MA, Decoud MSP, Paiva MSMO, Sanchez-Zambrano MB, Campos MDSB, Acevedo M, Ramirez MS, Souza OF, Medeiros OO, Carvalho RCM, Machado RB, Silva SCTFD, Rodrigues TCV, Avila WS, Costa-Paiva LHSD, Wender MCO. Oliveira GMM, et al. Among authors: rodrigues mah. Arq Bras Cardiol. 2024 Aug 16;121(7):e20240478. doi: 10.36660/abc.20240478. Arq Bras Cardiol. 2024. PMID: 39166619 Free PMC article. English, Portuguese. No abstract available.
Admixture's impact on Brazilian population evolution and health.
Nunes K, Araújo Castro E Silva M, Rodrigues MR, Lemes RB, Pezo-Valderrama P, Kimura L, de Sena LS, Krieger JE, Catoia Varela M, de Azevedo LO, Aranha Camargo LM, Ferreira RGM, Krieger H, Bortolini MC, Mill JG, Sacuena P, Guerreiro JF, de Souza CMB, Veronese FV, Vianna FSL, Comas D, Pereira AC, Pereira LV, Hünemeier T. Nunes K, et al. Among authors: rodrigues mr. Science. 2025 May 15;388(6748):eadl3564. doi: 10.1126/science.adl3564. Epub 2025 May 15. Science. 2025. PMID: 40373151
Atezolizumab Combined With Bevacizumab and Platinum-Based Therapy for Platinum-Sensitive Ovarian Cancer: Placebo-Controlled Randomized Phase III ATALANTE/ENGOT-ov29 Trial.
Kurtz JE, Pujade-Lauraine E, Oaknin A, Belin L, Leitner K, Cibula D, Denys H, Rosengarten O, Rodrigues M, de Gregorio N, Martinez García J, Petru E, Kocián R, Vergote I, Pautier P, Schmalfeldt B, Gaba L, Polterauer S, Mouret Reynier MA, Sehouli J, Churruca C, Selle F, Joly F, D'Hondt V, Bultot-Boissier É, Lebreton C, Lotz JP, Largillier R, Heudel PE, Heitz F; ATALANTE/ENGOT-ov29 Investigators. Kurtz JE, et al. Among authors: rodrigues m. J Clin Oncol. 2023 Oct 20;41(30):4768-4778. doi: 10.1200/JCO.23.00529. Epub 2023 Aug 29. J Clin Oncol. 2023. PMID: 37643382 Free PMC article. Clinical Trial.
[SFC in 2024].
Rodrigues M. Rodrigues M. Bull Cancer. 2024 Jan;111(1):3-4. doi: 10.1016/j.bulcan.2023.12.006. Bull Cancer. 2024. PMID: 38245331 French. No abstract available.
Single cell and spatial analysis of immune-hot and immune-cold tumours identifies fibroblast subtypes associated with distinct immunological niches and positive immunotherapy response.
Jenkins BH, Tracy I, Rodrigues MFSD, Smith MJL, Martinez BR, Edmond M, Mahadevan S, Rao A, Zong H, Liu K, Aggarwal A, Li L, Diehl L, King EV, Bates JG, Hanley CJ, Thomas GJ. Jenkins BH, et al. Among authors: rodrigues mfsd. Mol Cancer. 2025 Jan 6;24(1):3. doi: 10.1186/s12943-024-02191-9. Mol Cancer. 2025. PMID: 39757146 Free PMC article.
Maintenance with mirvetuximab soravtansine plus bevacizumab vs bevacizumab in FRα-high platinum-sensitive ovarian cancer.
O'Malley DM, Myers T, Wimberger P, Van Gorp T, Redondo A, Cibula D, Nicum S, Rodrigues M, Backes FJ, Barlin JN, Lewin SN, Lim P, Pothuri B, Diver E, Banerjee S, Lorusso D. O'Malley DM, et al. Among authors: rodrigues m. Future Oncol. 2024;20(32):2423-2436. doi: 10.1080/14796694.2024.2372241. Epub 2024 Jul 31. Future Oncol. 2024. PMID: 39082675 Free PMC article.
Prospective assessment of circulating tumor DNA in patients with metastatic uveal melanoma treated with tebentafusp.
Rodrigues M, Ramtohul T, Rampanou A, Sandoval JL, Houy A, Servois V, Mailly-Giacchetti L, Pierron G, Vincent-Salomon A, Cassoux N, Mariani P, Dutriaux C, Pracht M, Ryckewaert T, Kurtz JE, Roman-Roman S, Piperno-Neumann S, Bidard FC, Stern MH, Renault S. Rodrigues M, et al. Nat Commun. 2024 Oct 14;15(1):8851. doi: 10.1038/s41467-024-53145-0. Nat Commun. 2024. PMID: 39402032 Free PMC article. Clinical Trial.
Atezolizumab Combined With Platinum and Maintenance Niraparib for Recurrent Ovarian Cancer With a Platinum-Free Interval >6 Months: ENGOT-OV41/GEICO 69-O/ANITA Phase III Trial.
González-Martín A, Rubio MJ, Heitz F, Depont Christensen R, Colombo N, Van Gorp T, Romeo M, Ray-Coquard I, Gaba L, Leary A, De Sande LM, Lebreton C, Redondo A, Fabbro M, Barretina Ginesta MP, Follana P, Pérez-Fidalgo JA, Rodrigues M, Santaballa A, Sabatier R, Bermejo-Pérez MJ, Lotz JP, Pardo B, Marquina G, Sánchez-Lorenzo L, Quindós M, Estévez-García P, Guerra Alía E, Manso L, Casado V, Kommoss S, Tognon G, Henry S, Bruchim I, Oaknin A, Selle F. González-Martín A, et al. Among authors: rodrigues m. J Clin Oncol. 2024 Dec 20;42(36):4294-4304. doi: 10.1200/JCO.24.00668. Epub 2024 Sep 18. J Clin Oncol. 2024. PMID: 39292975 Clinical Trial.
4,950 results